ArticleHuman vaccines & immunotherapeutics2022
Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age.
Gary S Marshall et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.